Oakmark Funds, advised by Harris Associates, released its “Oakmark Global Fund” second quarter 2025 investor letter, underperforming the MSCI World Index. Top contributors were industrials and financials, while health care and energy detracted. Becton, Dickinson and Company (NYSE:BDX) stock closed at $177.09 per share on July 14, 2025, with a market capitalization of $50.755 billion.

Oakmark Global Fund highlighted Becton, Dickinson and Company (NYSE:BDX) in its investor letter. The company develops medical supplies and devices. Its stock had a one-month return of 4.21% and lost 23.24% over the last 52 weeks. BDX was the top detractor due to weak earnings impacted by research spending cuts and other challenges.

54 hedge fund portfolios held Becton, Dickinson and Company (NYSE:BDX) at the end of the first quarter. While BDX has investment potential, some AI stocks may offer greater upside with less downside risk. Consider exploring AI stocks for investment opportunities.

Read more at Yahoo Finance: Becton, Dickinson and Company (BDX) Traded Down on Weak Earnings